Author

Vindi Jurinović

Helmholtz MunichORCID 0009-0004-9087-0575Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Ambrine SahaliD· 1 shared Amelie MuthiD· 1 shared Annette Frank· 1 shared Annika Maria Dufour· 1 shared Binje VickiD· 1 shared Chiara Arnreich· 1 shared Christian RécheriD· 1 shared Christian ThiedeiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ambrine SahalORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A platform of robust patient-derived leukemia models covering subgroups for which no cell lines exist

Binje Vick, Vindi Jurinović, Kristina Kuhbandner, Lena Lagally, Lisa Latzko, Chiara Arnreich, Gerulf Hänel, Amelie Muth, Maja Rothenberg‐Thurley, Annika Maria Dufour, Stephanie E. Schneider, Lesca Miriam Holdt, Liliana Mura, Fabian Klein, Annette Frank, , Irmela Jeremias

The paper develops patient-derived AML PDX models that replicate primary AML biology and include subgroups lacking existing models, showing reduced leukemia growth after long-term chemotherapy.

bioRxiv · Sep 26, 2025 · PreprintCancer Biology